Coronavirus information from UCLA and UCLA Health.


The Next Generation Incubator

Appia Bio is a biotechnology startup dedicated to the discovery and development of allogeneic cell therapies with a scalability that increases access for cancer patients.


Cell therapy has brought dramatic improvements in efficacy and durable remission rates in certain hematological cancers, but it has reached a limited number of patients. Appia's novel, proprietary platform can programmably generate a broad array of NKT and T cell types from hematopoietic stem cells. Through breakthrough engineering technologies, Appia Bio aims to make cell therapy readily available for patients by generating allogeneic and off-the-shelf products.

Graduated: 2021
Location: Culver City, CA


Back to Top